MedTrace Logo

Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B

NCT06896630 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 172

Last updated 2025-04-04

No results posted yet for this study

Summary

Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year Period

Conditions

  • Tenofovir Disoproxil Fumarate
  • Renal Function Disorder
  • Chronic HBV Infection

Interventions

DRUG

Tenofovir Disoproxil Fumarate (TDF)

ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Effat AbdelHady Tony Ahmed, PROFESSOR OF NEPHROLOGY · Assiut University

  • Mohamed Abdelhakim Omran Mahdy, LECTRURER · Assiut University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-10
Primary Completion
2026-03-01
Completion
2026-05-01
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06896630 on ClinicalTrials.gov